ClinicalTrials.gg
DrugBiological

Fibrinogen clinical trials

Also written Haemocomplettan P and EVARREST.

studies test it
62
open now
1
in phase 3
19
first study started
2005

How each study uses Fibrinogen is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Fibrinogen studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
16 Jan 2009 · Riastap · BLA 125317 (FDA, Purple Book)
European Union
8 Jun 2004 · TachoSil · EMEA/H/C/000505 (EMA; in a combination)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Fibrinogen concentrate
17
RiaSTAP
16
Fibrinogen
9
Human fibrinogen concentrate
7
Fibrinogen Concentrate Human
6

Brand

Haemocomplettan P
7
EVARREST
2
Raplixa
2

In one entry with another drug

Given together, or one or the other

EVICEL® Fibrin Sealant
5
Evicel
5
EVICEL, fibrin sealant
2

Studies by the year they started

62 studies that test it; most in 2014 (8)

Studies that test Fibrinogen, by start year
YearStudies
20051
20072
20082
20093
20106
20116
20124
20131
20148
20156
20162
20172
20185
20192
20202
20213
20224
20232
20251

By phase

A phase 1/2 study counts in both.

Phase 1
4
Phase 2
23
Phase 3
19
Phase 4
15
No phase
8

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 16 · Other 46

Ethicon, Inc. (7) · IRCCS Policlinico S. Donato (3) · CSL Behring (3) · Emory University (2) · Gold Coast Hospital and Health Service (2) · Mallinckrodt (2) · Sahlgrenska University Hospital (2) · Brno University Hospital (1)

Often tested with

Tested in the same studies.

Thrombin (10) · Cryoprecipitate (2) · Prothrombin complex concentrates (1) · Prothrombin complex concentrate (1)

Studies

Open first, then newest update. How each study uses Fibrinogen is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 62

See all 62 studies that test Fibrinogen →

As the comparator · 1 — what is tested is compared with Fibrinogen

What changed recently

From the registry's own updates since Oct 20, 2026.

Codes

What other systems call Fibrinogen · ClinicalTrials.gg INT007488

  • UNII (FDA) N94833051KFIBRINOGEN HUMANConfirmed FDA, Wikidata
  • RxNorm 2264108One source FDA
  • Wikidata Q22075876human fibrinogenConfirmed FDA, Wikidata
  • NCI Thesaurus C81126Fibrinogen HumanConfirmed FDA, Wikidata
  • DrugBank DB09222One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.